MarketCap
Facebook
X
TelegramQuarterly report 2022-Q4
added 02-09-2023
Quotient Limited Total Inventories 2011-2026 | QTNT
Annual Total Inventories Quotient Limited
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 22 M | 20.5 M | 15.6 M | 16.3 M | 13.6 M | 12.6 M | 4.61 M | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22 M | 4.61 M | 15 M |
Quarterly Total Inventories Quotient Limited
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 14.3 M | 12.8 M | 22.1 M | 22 M | 22.8 M | 25 M | 23.2 M | 23.2 M | 23.7 M | 23.7 M | 22.8 M | 21.3 M | 19.8 M | 18.1 M | 16.7 M | 15.6 M | 15.3 M | 15.3 M | 15.6 M | 16.3 M | 16.5 M | 15.2 M | 14.8 M | 13.6 M | 13.2 M | 13.4 M | 12.8 M | 12.6 M | 7.81 M | 5.83 M | 5.01 M | 4.61 M | 4.59 M | 4.42 M | 4.64 M | 4.56 M | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 25 M | 4.42 M | 15.1 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aspira Women's Health
AWH
|
316 K | - | -6.19 % | $ 10.5 M |  USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
123 M | $ 29.14 | -3.75 % | $ 326 M |  China |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
13.3 M | $ 1.1 | 0.46 % | $ 1.4 M | USA |
 |
Co-Diagnostics
CODX
|
1.66 M | - | - | $ 79.8 M | USA |
 |
DarioHealth Corp.
DRIO
|
5.06 M | $ 11.38 | 1.16 % | $ 323 M |  Israel |
 |
DexCom
DXCM
|
629 M | $ 70.29 | 8.0 % | $ 27.4 B | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 32.89 | 3.09 % | $ 914 M | USA |
 |
Danaher Corporation
DHR
|
2.33 B | $ 211.14 | -1.74 % | $ 154 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
188 M | $ 205.13 | -0.82 % | $ 22.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M | China |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
CareDx, Inc
CDNA
|
19.5 M | $ 19.6 | 2.62 % | $ 1.05 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Interpace Biosciences
IDXG
|
1.21 M | $ 1.85 | - | $ 8.12 M | USA |
 |
Exact Sciences Corporation
EXAS
|
162 M | $ 103.32 | 0.09 % | $ 19.1 B | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
Lantheus Holdings
LNTH
|
68 M | $ 68.71 | -0.02 % | $ 4.75 B | USA |
 |
Guardant Health
GH
|
71.1 M | $ 104.76 | 1.95 % | $ 12.9 B | USA |
 |
QIAGEN N.V.
QGEN
|
279 M | - | - | $ 10.6 B |  Niderland |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Charles River Laboratories International
CRL
|
279 M | $ 160.2 | 0.91 % | $ 8.23 B | USA |
 |
IDEXX Laboratories
IDXX
|
382 M | $ 627.58 | 1.68 % | $ 51.8 B | USA |
 |
Illumina
ILMN
|
547 M | $ 115.9 | 1.27 % | $ 18.4 B | USA |
 |
OPKO Health
OPK
|
56.8 M | $ 1.24 | 2.48 % | $ 861 M | USA |
 |
Natera
NTRA
|
35.4 M | $ 204.66 | -1.53 % | $ 20.1 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
493 M | $ 281.39 | 1.13 % | $ 23.6 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 95.34 | 19.06 % | $ 7.86 B |  Irlanda |
 |
Biomerica
BMRA
|
1.49 M | $ 2.25 | 4.19 % | $ 5.17 M | USA |
 |
Bioventus
BVS
|
91.3 M | $ 8.22 | 1.48 % | $ 515 M | USA |